Ventral hernia repair using bioresorbable poly-4-hydroxybutyrate mesh in clean and contaminated surgical fields: a systematic review and meta-analysis.
Biosynthetic mesh
Meta-analysis
P4HB
Ventral hernia repair
Journal
Hernia : the journal of hernias and abdominal wall surgery
ISSN: 1248-9204
Titre abrégé: Hernia
Pays: France
ID NLM: 9715168
Informations de publication
Date de publication:
12 Feb 2024
12 Feb 2024
Historique:
received:
30
10
2023
accepted:
16
12
2023
medline:
12
2
2024
pubmed:
12
2
2024
entrez:
12
2
2024
Statut:
aheadofprint
Résumé
Use of biologic or synthetic mesh in hernia repair shifts is based on evolving evidence. Poly-4-hydroxybutyrate (P4HB) biosynthetic mesh is a potential alternative to biologic and synthetic mesh in ventral hernia repair (VHR). This meta-analysis assesses the efficacy of P4HB mesh in clean and contaminated surgical settings. Two authors searched literature on PubMed, reviewing titles and abstracts of all articles to determine inclusion eligibility. Post-operative data were compared via transformation method to convert the proportion of patients with the outcome of interest into a suitable quantity for random-effects synthesis using STATA software. Initial search yielded 287 citations. Six studies were included and categorized on whether hernia repairs were conducted in clean (CDC class I) or contaminated cases (CDC class II-IV). The pooled proportion of surgical site infection (SSI), surgical site occurrence (SSO), hernia recurrence, total surgical complications, and reoperation were calculated in 391 clean and 81 contaminated cases. For clean vs. contaminated cases, the following pooled proportions were noted: SSI (2% (CI 0-7%) vs 9% (CI 0-025) (p = 0.03), SSO: 14% (CI 5-25%) vs 35% (CI 22-50%) (p = 0.006), hernia recurrence (8% (CI 1-19%) vs 4% (CI 0-12%) (p = 0.769); surgical complications (17% (CI 6-32%) vs 50% (CI 27-72%) (p = 0.009). Reoperation data were available in 298 clean cases across four studies: 5% (CI 0-15%). P4HB biosynthetic mesh may be more effective than previously thought, particularly in clean wounds. P4HB may also be superior to biologic mesh when compared to clinical trial data. Further research is necessary for more direct comparison.
Identifiants
pubmed: 38345668
doi: 10.1007/s10029-023-02951-4
pii: 10.1007/s10029-023-02951-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.
Références
Muysoms FE, Miserez M, Berrevoet F, Campanelli G, Champault GG, Chelala E et al (2009) Classification of primary and incisional abdominal wall hernias. Hernia 13(4):407–414
doi: 10.1007/s10029-009-0518-x
pubmed: 19495920
pmcid: 2719726
Mazzola Poli de Figueiredo S, Tastaldi L, Mao RD, Lima DL, Huang LC, Lu R (2023) Biologic versus synthetic mesh in open ventral hernia repair: a systematic review and meta-analysis of randomized controlled trials. Surgery 173(4):1001–7
Poulose BK, Shelton J, Phillips S, Moore D, Nealon W, Penson D et al (2012) Epidemiology and cost of ventral hernia repair: making the case for hernia research. Hernia 16(2):179–183
doi: 10.1007/s10029-011-0879-9
pubmed: 21904861
Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J (2004) Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg 240(4):578–83; discussion 83–5
Shankaran V, Weber DJ, Reed RL 2nd, Luchette FA (2011) A review of available prosthetics for ventral hernia repair. Ann Surg 253(1):16–26
doi: 10.1097/SLA.0b013e3181f9b6e6
pubmed: 21135699
Rosen MJ, Krpata DM, Petro CC, Carbonell A, Warren J, Poulose BK et al (2022) Biologic vs synthetic mesh for single-stage repair of contaminated ventral hernias: a randomized clinical trial. JAMA Surg 157(4):293–301
doi: 10.1001/jamasurg.2021.6902
pubmed: 35044431
pmcid: 8771431
Martin DP, Badhwar A, Shah DV, Rizk S, Eldridge SN, Gagne DH et al (2013) Characterization of poly-4-hydroxybutyrate mesh for hernia repair applications. J Surg Res 184(2):766–773
doi: 10.1016/j.jss.2013.03.044
pubmed: 23582230
Deeken CR, Chen DC, Lopez-Cano M, Martin DP, Badhwar A (2023) Fully resorbable poly-4-hydroxybutyrate (P4HB) mesh for soft tissue repair and reconstruction: a scoping review. Front Surg 10:1157661
doi: 10.3389/fsurg.2023.1157661
pubmed: 37123542
pmcid: 10130450
Charleux-Muller D, Romain B, Boisson C, Velten M, Brigand C, Lejeune C (2022) Cost-effectiveness analysis of resorbable biosynthetic mesh in contaminated ventral hernia repair. J Visc Surg 159(4):279–285
doi: 10.1016/j.jviscsurg.2021.06.001
pubmed: 34116953
FitzGerald JF, Kumar AS (2014) Biologic versus synthetic mesh reinforcement: what are the pros and cons? Clin Colon Rectal Surg 27(4):140–148
doi: 10.1055/s-0034-1394155
pubmed: 26106284
pmcid: 4477030
Dayton MT, Buchele BA, Shirazi SS, Hunt LB (1986) Use of an absorbable mesh to repair contaminated abdominal-wall defects. Arch Surg 121(8):954–960
doi: 10.1001/archsurg.1986.01400080100019
pubmed: 3015071
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188
doi: 10.1016/0197-2456(86)90046-2
pubmed: 3802833
Kendall MG, Stuart A, Ord JK, Arnold SF, O’Hagan A (1994) Kendall’s advanced theory of statistics, 6th ed. London, New York: Edward Arnold, Halsted Press. v. <v. 1, 2A, B in 4> p
Cochrane Informatics and Knowledge Management Department. In: RevMan 5.3. 2014. Available from: https://community.cochrane.org/help/tools-and-software/revman-5
StataCorp L (2007) Stata data analysis and statistical software. Special Edition Release 10:733
Plymale MA, Davenport DL, Dugan A, Zachem A, Roth JS (2018) Ventral hernia repair with poly-4-hydroxybutyrate mesh. Surg Endosc 32:1689–1694
doi: 10.1007/s00464-017-5848-7
pubmed: 28916979
Aldohayan A, Alamri H, Aljunidel R, et al (2021) Laparoscopic ventral hernia repair with poly-4-hydroxybutyrate absorbable barrier composite mesh. JSLS 25
Roth JS, Anthone GJ, Selzer DJ et al (2018) Prospective evaluation of poly-4-hydroxybutyrate mesh in CDC class I/high-risk ventral and incisional hernia repair: 18-month follow-up. Surg Endosc 32:1929–1936
doi: 10.1007/s00464-017-5886-1
pubmed: 29063307
Hope WW, El-Ghazzawy AG, Winterstein BA et al (2022) A prospective, multicenter trial of a long-term bioabsorbable mesh with Sepra technology in cohort of challenging laparoscopic ventral or incisional hernia repairs (ATLAS trial). Ann Med Surg 73:103156
doi: 10.1016/j.amsu.2021.103156
Christopher AN, Morris MP, Patel V et al (2021) An evaluation of clinical and quality of life outcomes after ventral hernia repair with poly-4-hydroxybutyrate mesh. Hernia 25:717–726
doi: 10.1007/s10029-021-02394-9
pubmed: 33907919
Messa CA, Kozak G, Broach RB, Fischer JP (2019) When the mesh goes away: an analysis of poly-4-hydroxybutyrate mesh for complex hernia repair. Plast Reconstr Surg Glob Open 7:e2576
doi: 10.1097/GOX.0000000000002576
pubmed: 31942324
pmcid: 6908335
Miserez M, Lefering R, Famiglietti F et al (2021) Synthetic versus biological mesh in laparoscopic and open ventral hernia repair (LAPSIS): results of a multinational, randomized, controlled, and double-blind trial. Ann Surg 273:57–65
doi: 10.1097/SLA.0000000000004062
pubmed: 33332873
Holihan JL, Flores-Gonzalez JR, Mo J, Ko TC, Kao LS, Liang MK (2017) How long is long enough to identify a surgical site infection? Surg Infect (Larchmt) 18:419–423
doi: 10.1089/sur.2016.132
pubmed: 28004989
Ramsay G, Scott NW, Jansen JO (2020) A 19 year population-based cohort study analysing reoperation for recurrence following laparoscopic and open inguinal hernia repairs. Hernia 24:793–800
doi: 10.1007/s10029-019-02073-w
pubmed: 31786699
Davila DG, Parikh N, Frelich MJ, Goldblatt MI (2016) The increased cost of ventral hernia recurrence: a cost analysis. Hernia 20:811–817
doi: 10.1007/s10029-016-1515-5
pubmed: 27350558
DeBord J, Novitsky Y, Fitzgibbons R, Miserez M, Montgomery A (2018) SSI, SSO, SSE, SSOPI: the elusive language of complications in hernia surgery. Hernia 22:737–738
doi: 10.1007/s10029-018-1813-1
pubmed: 30203373